These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35616137)

  • 1. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.
    Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
    Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
    Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
    Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
    Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
    Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
    Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway.
    Yang R; Wang M; Zhang G; Li Y; Wang L; Cui H
    Cell Death Dis; 2021 Apr; 12(5):433. PubMed ID: 33931589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
    Mei X; Xiong J; Liu J; Huang A; Zhu D; Huang Y; Wang H
    Cancer Lett; 2024 Mar; 584():216609. PubMed ID: 38211648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBM15 m
    Song Y; Wu Q
    Environ Toxicol; 2023 Sep; 38(9):2155-2164. PubMed ID: 37334762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.
    Hu W; Hu Y; Pei Y; Li R; Xu F; Chi X; Mi J; Bergquist J; Lu L; Zhang L; Yang C
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
    J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
    Gong X; Tang H; Yang K
    Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis.
    Du Q; Liu P; Zhang C; Liu T; Wang W; Shang C; Wu J; Liao Y; Chen Y; Huang J; Tan H; Zhao Y; Xia M; Liu J; Yao S
    Cell Death Dis; 2022 May; 13(5):488. PubMed ID: 35597782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
    Li Z; Jin Q; Sun Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
    Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; He J; Ge Y; Yi W; Wu M; Li G; Zhou Y
    Int J Oncol; 2017 Nov; 51(5):1497-1507. PubMed ID: 29048616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability.
    Zhang C; Jiang H; Yuan L; Liao Y; Liu P; Du Q; Pan C; Liu T; Li J; Chen Y; Huang J; Liang Y; Xia M; Xu M; Qin S; Zou Q; Liu Y; Huang H; Pan Y; Li J; Liu J; Wang W; Yao S
    Oncogene; 2023 Mar; 42(11):793-807. PubMed ID: 36658304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.